Boehringer Ingelheim InPedILD Phase III trial showed encouraging results for both primary endpoints
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
Hello Patients provides healthcare billing and patients’ management solution
The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly
The unit has filed 2 Derma products and 1 MDI product.
3D CMOS chip for connecting electroactive tissues and organoids to software
The company continues to cooperate with the US FDA and is committed to undertake all necessary steps required to address their observations at the earliest
75 inter-disciplinary, multi-institutional grants would be supported for high-risk, ambitious research ideas, milestones-driven collaborative research in all domain areas of the biotech sector
The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
Subscribe To Our Newsletter & Stay Updated